Skip to main content
. Author manuscript; available in PMC: 2019 Feb 25.
Published in final edited form as: Free Radic Biol Med. 2018 Jul 3;124:517–524. doi: 10.1016/j.freeradbiomed.2018.06.040

Fig. 1.

Fig. 1.

A – Illustration of the study design. B, C - C-I activity and the D-form content in naïve (n = 6) and HI-brains at the end of HI-insult (0 min of reperfusion, n = 4), at 15 (n = 4) and 30 min of reperfusion (n = 6). D – The D-form content in naïve (n = 4) and HI-mice treated with vehicle (veh, n = 6) or with MitoSNO (n = 6). E - MitoSNO inactive metabolite (MitoNAP) in different regions of the brain following intranasal administration of MitoSNO to HI-mice (n = 5). F and G – Activities of C-II and C-IV in naïve (n = 6) and HI-mouse brains (n = 4–6).